RESUMEN
Delta-aminolevulinic acid, precursor of heme, accumulates in a number of organs, especially in the liver, of patients with acute intermittent porphyria. The potential protective effect of melatonin against oxidative damage to nuclear DNA and microsomal and mitochondrial membranes in rat liver, caused by delta-aminolevulinic acid, was examined. Changes in 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels, an index of DNA damage, and alterations in membrane fluidity (the inverse of membrane rigidity) and lipid peroxidation in microsomal and mitochondrial membranes, as indices of damage to lipid and protein molecules in membranes, were estimated. Measurements were made in rat liver after a 2 week treatment with delta-aminolevulinic acid (40 mg/kg b.w., every other day). To test the potential protective effects of melatonin, the indole was injected (i.p. 10 mg/kg b.w.) 3 times daily for 2 weeks. 8-OHdG levels and lipid peroxidation in microsomal membranes increased significantly whereas microsomal and mitochondrial membrane fluidity decreased as a consequence of delta-aminolevulinic acid treatment. Melatonin completely counteracted the effects of delta-aminolevulinic acid. Melatonin was highly effective in protecting against oxidative damage to DNA as well as to microsomal and mitochondrial membranes in rat liver and it may be useful as a cotreatment in patients with acute intermittent porphyria.
Asunto(s)
Ácido Aminolevulínico/toxicidad , Daño del ADN , Desoxiguanosina/análogos & derivados , Hígado/fisiología , Melatonina/farmacología , Estrés Oxidativo/fisiología , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Desoxiguanosina/análisis , Membranas Intracelulares/efectos de los fármacos , Membranas Intracelulares/fisiología , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Fluidez de la Membrana/efectos de los fármacos , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/fisiología , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/fisiología , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Sprague-DawleyRESUMEN
The complex processes of carcinogenesis often involve oxidative stress. Numerous indicators of oxidative damage are enhanced as the result of the action of carcinogens. Several antioxidants, with different efficacies, protect against oxidative abuse caused by carcinogens. Recently, melatonin (N-acetyl-5-methoxytryptamine) and related indoleamines have attracted attention because of their high antioxidant and anticarcinogenic activity. Some antioxidants, e.g. ascorbic acid, play an ambivalent role in antioxidative defense, since, under specific conditions, they are strongly prooxidant. Among known antioxidants, melatonin has been an often investigated experimental agent in reducing cancer initiation and inhibiting the growth of established tumors. The indoleamine has been shown to protect macromolecules from oxidative mutilation induced by carcinogens. In these studies, a variety of in vitro and in vivo models were used and numerous indices of oxidative damage were evaluated. The protective effects of melatonin and several other indoleamine antioxidants against cellular damage caused by carcinogens make them potential supplements in the treatment or co-treatment at several stages of cancer.
Asunto(s)
Anticarcinógenos/farmacología , Antioxidantes/farmacología , Melatonina/farmacología , Ácido Aminolevulínico/farmacología , Animales , Anticarcinógenos/química , Antioxidantes/química , Carcinógenos/metabolismo , Humanos , Melatonina/química , Metales/metabolismo , Estructura Molecular , Oxidación-Reducción , Fenilhidrazinas/farmacologíaRESUMEN
Phenylhydrazine and iron overload result in augmented oxidative damage and an increased likelihood of cancer. Melatonin is a well known antioxidant and free radical scavenger. The aim of this study was to determine whether melatonin would protect against phenylhydrazine-induced oxidative damage to cellular membranes and to evaluate the possible role of iron in this process. Changes in lipid peroxidation and microsomal membrane fluidity were estimated after the treatment of rats with phenylhydrazine (15 mg/kg body weight, daily, 7 days) alone and melatonin or ascorbic acid (15 mg/kg body weight, two times daily, 8 days), or their combination. Additionally, lipid peroxidation was measured in liver homogenates from untreated and melatonin or ascorbic acid-treated rats in vivo and exposed to iron in vitro. Melatonin, but not ascorbic acid, reduced phenylhydrazine-induced lipid peroxidation in vivo in spleen (3.16+/-0.06 vs. 3.83+/-0.12 nmol/mg protein, P<0.05) and plasma (7. 73+/-0.52 vs. 9.96+/-0.71 nmol/ml, P<0.05) and attenuated the decrease in hepatic microsomal membrane fluidity (1/polarization, 3. 068+/-0.007 vs. 3.027+/-0.008, P<0.05). In vitro exposure to iron significantly enhanced the lipid peroxidation in liver homogenates from untreated (3.34+/-0.75 vs. 1.25+/-0.28, P<0.05) or ascorbic acid-treated rats (2.72+/-0.39 vs. 0.88+/-0.06, P<0.05) but not from melatonin-treated rats (1.49+/-0.55 vs. 0.68+/-0.20, NS). It is concluded that free radical mechanisms are involved in the toxicity of phenylhydrazine and that the antioxidant melatonin, but not ascorbic acid, reduces the toxic affects of phenylhydrazine in vivo and of iron in vitro in cell membranes. Therefore, melatonin co-treatment in conditions of iron overload may prove beneficial.
Asunto(s)
Membranas Intracelulares/efectos de los fármacos , Hierro/metabolismo , Melatonina/metabolismo , Estrés Oxidativo/efectos de los fármacos , Fenilhidrazinas/farmacología , Animales , Ácido Ascórbico/farmacología , Depuradores de Radicales Libres/farmacología , Membranas Intracelulares/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/análogos & derivados , Malondialdehído/metabolismo , Fluidez de la Membrana/efectos de los fármacos , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
Chromium (Cr) compounds are widely used industrial chemicals and well known carcinogens. Cr(III) was earlier found to induce oxidative damage as documented by examining the levels of 8-hydroxydeoxyguanosine (8-OH-dG), an index for DNA damage, in isolated calf thymus DNA incubated with CrCl(3) and H(2)O(2). In the present in vitro study, we compared the ability of the free radical scavengers melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK), resveratrol and uric acid to reduce DNA damage induced by Cr(III). Each of these scavengers markedly reduced the DNA damage in a concentration-dependent manner. The concentrations that reduced 8-OH-dG formation by 50% (IC(50)) were 0.10 microM for both resveratrol and melatonin, and 0.27 microM for AFMK. However, the efficacy of the fourth endogenous antioxidant, i.e. uric acid, in terms of its inhibition of DNA damage in the same in vitro system was about 60--150 times less effective than the other scavengers; the IC(50) for uric acid was 15.24 microM. These findings suggest that three of the four antioxidants tested in these studies may have utility in protecting against the environmental pollutant Cr and that the protective effects of these free radical scavengers against Cr(III)-induced carcinogenesis may relate to their direct hydroxyl radical scavenging ability. In the present study, the formation of 8-OH-dG was likely due to a Cr(III)-mediated Fenton-type reaction that generates hydroxyl radicals, which in turn damage DNA. Once formed, 8-OH-dG can mutate eventually leading to cancer; thus the implication is that these antioxidants may reduce the incidence of Cr-related cancers.
Asunto(s)
Antioxidantes/farmacología , Daño del ADN/efectos de los fármacos , Kinuramina/farmacología , Melatonina/farmacología , Estilbenos/farmacología , Ácido Úrico/farmacología , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Cromatografía Líquida de Alta Presión , Compuestos de Cromo/farmacología , Desoxiguanosina/análogos & derivados , Desoxiguanosina/metabolismo , Peróxido de Hidrógeno/farmacología , Kinuramina/análogos & derivados , Estructura Molecular , ResveratrolRESUMEN
An increased incidence of cancer in patients suffering from acute intermittent porphyria (AIP) is thought to be related to delta-aminolevulinic acid (ALA) accumulation. Chronic treatment with ALA augmented 8-oxo-7,8-dihydro-2'-deoxyguanosine levels, decreased microsomal and mitochondrial membrane fluidity and increased lipid peroxidation in blood serum. Co-treatment with melatonin completely counteracted the effects of ALA. Melatonin effectively protects DNA and microsomal and mitochondrial membranes in rat kidney from oxidative damage due to ALA. Because of its low toxicity and anticarcinogenic properties, melatonin could be tested as an agent to reduce oxidative damage in patients with AIP.
Asunto(s)
Ácido Aminolevulínico/toxicidad , Antioxidantes/farmacología , Carcinógenos/toxicidad , Desoxiguanosina/análogos & derivados , Enfermedades Renales/inducido químicamente , Enfermedades Renales/prevención & control , Melatonina/farmacología , 8-Hidroxi-2'-Desoxicoguanosina , Ácido Aminolevulínico/farmacocinética , Animales , Carcinógenos/farmacocinética , ADN/efectos de los fármacos , ADN/metabolismo , Daño del ADN , Desoxiguanosina/metabolismo , Membranas Intracelulares/efectos de los fármacos , Riñón/efectos de los fármacos , Riñón/metabolismo , Enfermedades Renales/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/sangre , Fluidez de la Membrana/efectos de los fármacos , Microsomas/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Estrés Oxidativo , Ratas , Ratas Sprague-DawleyRESUMEN
Chromium compounds are well documented carcinogens. Cr(III) is more reactive than Cr(VI) toward DNA under in vitro conditions. In the present study, we investigated the ability of Cr(III) to induce oxidative DNA damage by examining the formation of 8-hydroxydeoxyguanosine (8-OH-dG) in calf thymus DNA incubated with CrCl(3) plus H(2)O(2). We measured 8-OH-dG using HPLC with electrochemical detection. In the presence of H(2)O(2), we observed that Cr(III)-induced formation of 8-OH-dG in isolated DNA was dose and time dependent. Melatonin, ascorbate, and vitamin E (Trolox), all of which are free radical scavengers, markedly inhibited the formation of 8-OH-dG in a concentration-dependent manner. The concentration that reduced DNA damage by 50% was 0.51, 30.4, and 36.2 microM for melatonin, ascorbate, and Trolox, respectively. The results show that melatonin is 60- and 70-fold more effective than ascorbate or vitamin E, respectively, in reducing oxidative DNA damage in this in vitro model. These findings also are consistent with the conclusion that the carcinogenic mechanism of Cr(III) is possibly due to Cr(III)-mediated Fenton-type reactions and that melatonin's highly protective effects against Cr(III) relate, at least in part, to its direct hydroxyl radical scavenging ability.
Asunto(s)
Antioxidantes/farmacología , Cromo/toxicidad , Daño del ADN , ADN/efectos de los fármacos , ADN/metabolismo , Desoxiguanosina/análogos & derivados , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Ácido Ascórbico/farmacología , Bovinos , ADN/química , Desoxiguanosina/metabolismo , Depuradores de Radicales Libres/farmacología , Humanos , Peróxido de Hidrógeno/toxicidad , Técnicas In Vitro , Melatonina/farmacología , Exposición Profesional , Vitamina E/farmacologíaRESUMEN
BACKGROUND: Iodine prophylaxis in Poland started in 1935 and has been interrupted twice: by World War II and in 1980 for economic reasons. Epidemiological surveys carried out after the Chernobyl accident in 1989 as well as in 1992/1993 and in 1994 as a 'ThyroMobil' study, revealed increased prevalence of goitre in children and adults. Ninety per cent of Poland was classified as an area of moderate iodine deficiency, and 10%, in the seaside area, as mild iodine deficiency territory. Iodine prophylaxis based on iodisation of household salt was introduced again in 1986 as a voluntary model and in 1997 as a mandatory model with 30+/-10 mg KI/kg salt. OBJECTIVE: The evaluation of the obligatory model of iodine prophylaxis in schoolchildren from the same schools in 1994 and 1999. METHODS: Thyroid volume was determined by ultrasonography. Ioduria in casual morning urine samples was measured using Sandell-Kolthoff's method, within the framework of the ThyroMobil study. RESULTS: Goitre prevalence decreased from 38.4 to 7% and urinary iodine concentration increased from 60.4 to 96.2 microg/l mean values between 1994 and 1999. In four schools the prevalence of goitre diminished below 5%. In 1999, 70% of children excreted over 60 microg I/l, and 36% over 100 microg I/l, whereas in 1994 the values were 44 and 13% respectively. CONCLUSION: The present findings indicate that iodine prophylaxis based only on iodised household salt is highly effective.
Asunto(s)
Yodo/uso terapéutico , Cloruro de Sodio Dietético/uso terapéutico , Enfermedades de la Tiroides/prevención & control , Adolescente , Niño , Femenino , Humanos , Yodo/orina , Masculino , Polonia/epidemiología , Factores Sexuales , Enfermedades de la Tiroides/epidemiologíaRESUMEN
The effects of omeprazole--an inhibitor of gastric acid secretion--on gastrin (G)- and somatostatin (D)-cell density in the gastric antral mucosa epithelium in rats were examined, following a 5-day treatment. It was found that omeprazole increased the density of G-cells, whereas it decreased the density of D-cells. That effect was probably independent of hypergastrinaemia, since it could not be blocked by a simultaneous treatment with proglumide--a gastrin receptor blocker. It is concluded that the observed phenomenon is a direct result of a lower gastric acidity, as a consequence of omeprazole treatment.
Asunto(s)
Mucosa Gástrica/efectos de los fármacos , Gastrinas/análisis , Omeprazol/farmacología , Somatostatina/análisis , Animales , Recuento de Células/efectos de los fármacos , Mucosa Gástrica/citología , Mucosa Gástrica/metabolismo , Inmunohistoquímica , Masculino , Octreótido/farmacología , Omeprazol/antagonistas & inhibidores , Proglumida/farmacología , Ratas , Ratas EndogámicasRESUMEN
Melatonin (N-acetyl-5-methoxytryptamine) was initially thought to be produced exclusively in the pineal gland. Subsequently its synthesis was demonstrated in other organs, for example, the retinas, and very high concentrations of melatonin are found at other sites, for example, bone marrow cells and bile. The origin of the high level of melatonin in these locations has not been definitively established, but it is likely not exclusively of pineal origin. Melatonin has been shown to possess anti-inflammatory effects, among a number of actions. Melatonin reduces tissue destruction during inflammatory reactions by a number of means. Thus melatonin, by virtue of its ability to directly scavenge toxic free radicals, reduces macromolecular damage in all organs. The free radicals and reactive oxygen and nitrogen species known to be scavenged by melatonin include the highly toxic hydroxyl radical (.OH), peroxynitrite anion (ONOO-), and hypochlorous acid (HOCl), among others. These agents all contribute to the inflammatory response and associated tissue destruction. Additionally, melatonin has other means to lower the damage resulting from inflammation. Thus, it prevents the translocation of nuclear factor-kappa B (NF-kappa B) to the nucleus and its binding to DNA, thereby reducing the upregulation of a variety of proinflammatory cytokines, for example, interleukins and tumor neurosis factor-alpha. Finally, there is indirect evidence that melatonin inhibits the production of adhesion molecules that promote the sticking of leukocytes to endothelial cells. By this means melatonin attenuates transendothelial cell migration and edema, which contribute to tissue damage.
Asunto(s)
Inmunidad/fisiología , Melatonina/inmunología , Animales , Humanos , Inflamación/inmunología , Inflamación/fisiopatología , NeuroinmunomodulaciónRESUMEN
Reactive oxygen and nitrogen species are generated by several inflammatory and structural cells of the airways. These oxidant species have important effects on a variety of lung cells as regulators of signal transduction, activators of key transcription factors and modulators of gene expression and apoptosis. Thus, increased oxidative stress accompanied by reduced endogenous antioxidant defenses may play a role in the pathogenesis of a number of inflammatory pulmonary diseases, including respiratory distress syndrome (RDS) in the newborn. There obviously are conflicting reports on the effect of oxygen, ventilation and nitric oxide (NO) on RDS and, thus, the question arises as what the neonatologist should do when confronted with a newborn with RDS. Clearly, utilizing lung protective strategies requires compromises between gas exchange goals and potential toxicities associated with over-distension, derecruitment of lung units and high oxygen concentrations. The results discussed in this brief review suggest rigorous clinical tests with antioxidants which may help to define the mechanisms associated with RDS and which could lead to new treatment strategies.
Asunto(s)
Recien Nacido Prematuro , Estrés Oxidativo , Síndrome de Dificultad Respiratoria del Recién Nacido/fisiopatología , Antioxidantes/metabolismo , Citocinas/sangre , Depuradores de Radicales Libres/uso terapéutico , Humanos , Recién Nacido , Óxido Nítrico/uso terapéuticoRESUMEN
N-acetylserotonin, the immediate precursor of melatonin in the tryptophan metabolic pathway in the pineal gland, has been reported to be an antioxidant. The aim of this work was to test the effect of N-acetylserotonin in stabilizing biological membranes against oxidative stress. Hepatic microsomal membranes from male adult rats were incubated with N-acetylserotonin (0.001-3 mM) before inducing lipid peroxidation using FeCl(3), ADP and NADPH. Control experiments were done by incubating microsomal membranes with N-acetylserotonin in the absence of lipid peroxidation-inducing drugs. Membrane fluidity was assessed by fluorescence spectroscopy and malonaldehyde plus 4-hydroxyalkenals concentrations were measured to estimate the degree of lipid peroxidation. Free radicals induced by the combination of FeCl(3)+ADP+NADPH produced a significant decrease in the microsomal membrane fluidity, which was associated with an increase in the malonaldehyde plus 4-hydroxyalkenals levels. These changes were suppressed in a concentration-dependent manner when N-acetylserotonin was added in the incubation buffer. In the absence of lipid peroxidation, N-acetylserotonin (0.001-3 mM) did not change membrane fluidity nor malonaldehyde plus 4-hydroxyalkenals levels. These results suggest that the protective role of N-acetylserotonin in preserving optimal levels of fluidity of the biological membranes may be related to its ability to reduce lipid peroxidation.
Asunto(s)
Peroxidación de Lípido/efectos de los fármacos , Fluidez de la Membrana/efectos de los fármacos , Membranas/efectos de los fármacos , Microsomas Hepáticos/efectos de los fármacos , Serotonina/análogos & derivados , Serotonina/farmacología , Aldehídos/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Masculino , Malondialdehído/metabolismo , Membranas/fisiología , Microsomas Hepáticos/metabolismo , Microsomas Hepáticos/fisiología , Ratas , Ratas Sprague-DawleyRESUMEN
Estrogens exert pro-oxidative effects and have been shown to damage DNA, potentially leading to cancer. Melatonin is a well-known antioxidant, free radical scavenger, and oncostatic agent. Changes in the levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo), an index of DNA damage, and the levels of malondialdehyde + 4-hydroxyalkenals, an index of lipid peroxidation, were measured in kidneys, liver, and testes from hamsters treated with E2 (75 mg/kg body wt) and were collected 3 or 5 hr later. Other animals were treated with melatonin (15 mg/kg body wt, 30 min before and 120 min after E2 treatment) or were given both compounds. Additionally, lipid peroxidation was measured in liver homogenates exposed to ferrous sulfate (15 microM) in vitro. E2 treatment caused an increase in 8-oxodGuo levels in kidneys collected 5 hr after E2 administration, and in liver 3 hr after estrogen treatment. Melatonin completely prevented E2-induced DNA damage in both organs. Melatonin alone or when given with E2 and examined 3 hr later decreased the base level of 8-oxodGuo in testes. A tendency for a reduction in in vivo lipid peroxidation was observed after treatment of hamsters with either melatonin, E2, or both compounds, with a statistically significant decrease being measured in the liver following E2 administration. In vitro exposure to iron significantly enhanced lipid peroxidation in hepatic homogenates from untreated, melatonin-treated, or E2-injected hamsters; in the hepatic homogenates of hamsters given both E2 and melatonin, ferrous sulfate failed to augment lipid peroxidation. Our results confirm the dual actions of estrogens relative to oxidative damage, i.e., estrogen increases oxidative destruction of DNA while reducing lipid peroxidation. Melatonin had antioxidative actions in reducing oxidative damage to both DNA and to membrane lipids. Melatonin completely prevented the damaging action of E2 on DNA and synergized with the steroid to reduce lipid peroxidation.
Asunto(s)
Daño del ADN/efectos de los fármacos , Estradiol/farmacología , Melatonina/farmacología , Neoplasias/prevención & control , Oxidantes/farmacología , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Cricetinae , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análisis , Riñón/química , Peroxidación de Lípido/efectos de los fármacos , Hígado/química , Masculino , Malondialdehído/análisis , Mesocricetus , Testículo/químicaRESUMEN
17beta-Estradiol (E(2)) is a known carcinogen. Estrogen induction of tumors in hamster kidney is a model of estrogen-related carcinogenesis. Melatonin is a well-known antioxidant, free radical scavenger and oncostatic agent. Changes in the levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo), an index of DNA damage, were measured in kidneys, liver and testes from hamsters treated with E(2) (75mg/kg b.w.) and collected 5h later. Potential protective effects of melatonin, N-acetylserotonin (NAS), indole-3-propionic acid (IPA) and ascorbic acid (AA) against E(2)-induced DNA damage were tested. The antioxidants were applied in equimolar doses of 64.5 micromol/kg b.w., 2 and 0.5h before and 2 and 4h after E(2) treatment. E(2) treatment caused a significant increase in 8-oxodGuo levels in kidneys, but did not influence significantly the oxidation of guanine bases in liver and testes. Melatonin, IPA and AA, but not NAS, completely prevented E(2)-induced DNA damage in hamster kidneys. It is concluded that melatonin, IPA and AA may be effective in protecting against E(2)-related DNA damage and, consequently, carcinogenesis.
Asunto(s)
Antioxidantes/farmacología , Daño del ADN , Estradiol/toxicidad , Riñón/efectos de los fármacos , Melatonina/farmacología , Animales , Cricetinae , Riñón/metabolismo , Neoplasias Renales/inducido químicamente , Neoplasias Renales/prevención & control , MesocricetusRESUMEN
The pharmacological effects of melatonin, vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) alone and in combination on iron-induced membrane lipid damage in rat liver homogenates were examined by estimating levels of malondialdehyde and 4-hydroxyalkenals (MDA+4-HDA). Individually, melatonin (2.5-1600 microM), vitamin E (0.5-50 microM), glutathione (100-7000 microM) and desferrioxamine (1-8 microM) inhibited lipid peroxidation in a concentration-dependent manner. Vitamin C had both a pro-oxidative (25-2000 microM) and an antioxidative (2600-5000 microM) effect. The IC50 (concentration that reduces damage by 50%) values were 4, 10, 426, 2290 and 4325 microM for vitamin E, desferrioxamine, melatonin, glutathione and vitamin C, respectively. The synergistic actions of melatonin with vitamin C, vitamin E, and glutathione were systematically investigated. When melatonin was combined with vitamin E, glutathione, or vitamin C, the protective effects against iron-induced lipid peroxidation were dramatically enhanced. Even though melatonin was added at very low concentrations, it still showed synergistic effects with other antioxidants at certain concentrations. Furthermore, melatonin not only reversed the pro-oxidative effects of vitamin C, but its efficacy in reducing lipid peroxidation was improved when it was combined with pro-oxidative concentrations of vitamin C. The results provide new information in terms of the possible pharmacological use of the combination of melatonin and classical antioxidants to treat free radical-related conditions.
Asunto(s)
Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Deferoxamina/farmacología , Glutatión/farmacología , Melatonina/farmacología , Vitamina E/farmacología , Animales , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Lípidos/química , Malondialdehído/química , Proteínas/química , RatasRESUMEN
This paper presents the results of studies performed within the Applied Project of the Ministry of Health and Social Welfare and of the Committee for Scientific Research: "Studies on Iodine Deficiency in Poland", including the school children in Lódz City and seven voivodships of the Central Poland. According to the results, the analyzed regions can be regarded as areas of goitrous endemia of a moderate degree (the goitre was found in 32.7% of examined population); the same regions can also be classified among the regions of mild iodine deficiency (the mean iodide concentration in urine was 64.0 micrograms/l). The obtained results prove the to-date's iodine prophylaxis to be not entirely efficient in the areas of interest, demanding an effective model of iodine complementation in diet to be designed.
Asunto(s)
Bocio Endémico/epidemiología , Yodo/deficiencia , Adolescente , Niño , Femenino , Alimentos Fortificados , Bocio Endémico/diagnóstico , Bocio Endémico/prevención & control , Humanos , Incidencia , Yodo/uso terapéutico , Yodo/orina , Masculino , Polonia/epidemiología , Glándula Tiroides/anatomía & histología , Salud UrbanaRESUMEN
2521 patients of the Lódz Outpatient Endocrinological Clinic (2290 females, 231 males; inhabitants of the central region of Poland Lódz City, Lódz Metropolitan Area, Piotrków, Plock, Sieradz, Skierniewice and Wloclawek Provinces in which committed dose equivalent to the thyroid was between 2.7-7.0 mSv [min.-max.] in Skierniewice Province and 4.6-11.7 mSv in Plock Province) were included in the study. The patients were divided into 5 groups: I--persons who did not take the protective dose of potassium iodide (KI) after Chernobyl Nuclear Power Plant accident and did not received any treatment with thyroid preparations or hormones at that time (n = 1282), II--patients who receive KI, once or several times (n = 774), III--patients who took orally iodine tincture or other iodine-containing preparations for the above purposes (n-37), IV--patients who took tablets of Thyroideum (Polfa) Thyroideum siccum (dry thyroid extract), once or several times, as a prophylactic action (n = 79), V--patients who were in the course of continuous treatment with Thyreoideum or thyroid hormones at the time of Chernobyl accident (n = 349). The analysis was performed for all the patients jointly, as well as separately for: either sex, three age groups (18-30, 31-55, 56-70 yrs) and 7 administrative areas specified above. All the patients were subjected into complex clinical examination, serum TSH, T3, T4 concentrations, anti-thyroid membrane antibodies (ATMA) and antithyroglobulin antibodies (ATg) titres, as well as ultrasound, scintigraphy, and fine needle aspiration biopsy of the thyroid (the last two according to indications) included. The patients were also examined by means of a special questionnaire (Patient's Inquiry Sheet), which was subsequently submitted to computer analysis. All the doctors' diagnoses from 1986 (17 different diagnoses) and 1990 (27 different diagnoses), as well as the course of diseases, were verified with use of a specially prepared IBM PC/AT computer program ChernStat.(ABSTRACT TRUNCATED AT 400 WORDS)
Asunto(s)
Contaminantes Radiactivos del Aire/efectos adversos , Yoduro de Potasio/uso terapéutico , Centrales Eléctricas , Liberación de Radiactividad Peligrosa , Enfermedades de la Tiroides/prevención & control , Adulto , Anciano , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Polonia/epidemiología , Encuestas y Cuestionarios , Enfermedades de la Tiroides/epidemiología , Enfermedades de la Tiroides/etiología , UcraniaRESUMEN
The effects of intravenous (i.v.) injections of vasoactive intestinal polypeptide (VIP) and intraperitoneal (i.p.) injections of thyroid-stimulating hormone (TSH, thyrotropin) on 3H-thymidine incorporation into the DNA of rat thyroid lobes incubated, after collecting, in vitro, were investigated. The animals of groups 1-6 were injected with the following substances: group 1, 0.9% NaCl; group 2, 2 IU TSH (i.p.); group 3, 10(-12) mol VIP; group 4, 10(-10) mol VIP; group 5, 10(-8) mol VIP; and group 6, 10(-8) mol VIP + 2 IU TSH (i.p.). The rats of each group were divided into three subgroups, and sacrificed after 6, 12 or 24 h from the time of injection. For group 1, the additional control group zero was used, and these controls were sacrificed immediately after i.v. injections of 0.9% NaCl at zero time. After decapitation the thyroid lobes were collected and then incubated for 4 h in RPMI 1640 medium in the presence of 3H-thymidine, 15% FCS and Hepes buffer. In all groups and at all times an increase of 3H-thymidine incorporation occurred; the stimulatory effect of VIP (in all doses) was stronger than that of TSH; the rate of 3H-thymidine incorporation after injections of both VIP and TSH (group 6), was higher than the rates following injections of VIP alone (group 5) or TSH alone (group 2).
Asunto(s)
Glándula Tiroides/efectos de los fármacos , Péptido Intestinal Vasoactivo/farmacología , Animales , División Celular/efectos de los fármacos , Replicación del ADN/efectos de los fármacos , Sinergismo Farmacológico , Inyecciones Intraperitoneales , Inyecciones Intravenosas , Masculino , Ratas , Ratas Wistar , Estimulación Química , Glándula Tiroides/citología , Glándula Tiroides/crecimiento & desarrollo , Tirotropina/administración & dosificación , Tirotropina/farmacología , Péptido Intestinal Vasoactivo/administración & dosificaciónRESUMEN
Ionizing radiation is classified as a potent carcinogen, and its injury to living cells is, to a large extent, due to oxidative stress. The molecule most often reported to be damaged by ionizing radiation is DNA. Hydroxyl radicals (*OH), considered the most damaging of all free radicals generated in organisms, are often responsible for DNA damage caused by ionizing radiation. Melatonin, N-acetyl-5-methoxytryptamine, is a well-known antioxidant that protects DNA, lipids, and proteins from free-radical damage. The indoleamine manifests its antioxidative properties by stimulating the activities of antioxidant enzymes and scavenging free radicals directly or indirectly. Among known antioxidants, melatonin is a highly effective scavenger of *OH. Melatonin is distributed ubiquitously in organisms and, as far as is known, in all cellular compartments, and it quickly passes through all biological membranes. The protective effects of melatonin against oxidative stress caused by ionizing radiation have been documented in in vitro and in vivo studies in different species and in in vitro experiments that used human tissues, as well as when melatonin was given to humans and then tissues collected and subjected to ionizing radiation. The radioprotective effects of melatonin against cellular damage caused by oxidative stress and its low toxicity make this molecule a potential supplement in the treatment or co-treatment in situations where the effects of ionizing radiation are to be minimized.
Asunto(s)
Antioxidantes/farmacología , Células/efectos de la radiación , Melatonina/farmacología , Radiación Ionizante , Animales , Daño del ADN , Radicales Libres , Humanos , Neoplasias Inducidas por Radiación/prevención & control , Estrés OxidativoRESUMEN
The aim of the present study was to examine the effects of melatonin (Mel) and of pinealectomy (PX) [in a long-term experiment in vivo - 10 weeks], as well as of Mel and N-acetylserotonin (NAc-5HT) [in experiments ex vivo in vitro and in vitro], on the rat thyroid growth processes. Additionally, the incubations in vitro of rat thyroid lobes with 3H-thymidine, in the presence of TSH, vasoactive intestinal polypeptide (VIP), VIP-antagonist ([4Cl-D-Ph6, Leu17]VIP), somatostatin (SS), all the substances used separately or jointly in combinations, were performed. It was shown that: (a) Mel--administered in late afternoon injections--decreased, while PX increased examined indices of thyroid growth in vivo, (b) Mel--administered in s.c. implanted pellets--reversed the inhibitory effect of Mel injections, (c) in experiments ex vivo in vitro and in vitro, the inhibitory effect of Mel revealed only for the lowest applied dose/concentration of the hormone, (d) NAc-5HT showed no effect, (e) VIP decreased 3H-thymidine incorporation into DNA of thyroid lobes in vitro and enhanced the inhibitory effect of SS on the process in question, (f) VIP-antagonist failed to reverse the inhibitory action of VIP on the thyroid growth.
Asunto(s)
Indoles/farmacología , Neuropéptidos/farmacología , Glándula Pineal/fisiología , Glándula Tiroides/crecimiento & desarrollo , Animales , ADN/metabolismo , Masculino , Melatonina/farmacología , Mitosis/efectos de los fármacos , Glándula Pineal/química , Ratas , Ratas Wistar , Serotonina/análogos & derivados , Serotonina/farmacología , Timidina/metabolismo , Glándula Tiroides/citología , Glándula Tiroides/efectos de los fármacos , Tirotropina/metabolismo , Péptido Intestinal Vasoactivo/farmacologíaRESUMEN
We examined the effect of vasoactive intestinal polypeptide (VIP) on thymidine kinase (TK) activity in the tissue of rat thyroid lobes incubated in vitro. Additionally, thyrotropin, epidermal growth factor, as well as atropine and carbachol were studied. It was shown that: 1. thyrotropin and epidermal growth factor did not essentially affect TK activity; 2. the effect of VIP was dose dependent: the high concentrations of peptide (10(-7) M and 10(-5) M) suppressed, while the lower concentrations (10(-15)M, 10(-13)M, 10(-11)M and 10(-9) M)-enhanced TK activity; 3. atropine tended to increase TK activity, however, that rise did not attain statistical significance; 4. VIP, when used together with atropine, decreased TK activity when compared with the activity in question after exposure to atropine alone; 5. carbachol suppressed TK activity; 6. the joint action of carbachol and VIP did not significantly change the activity of the examined enzyme.